NCT01714843View on ClinicalTrials.gov

A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

559

Participants

Timeline

Start Date

August 10, 2012

Primary Completion Date

December 7, 2013

Study Completion Date

December 7, 2013

Conditions
Constipation-predominant Irritable Bowel Syndrome (IBS-C)
Interventions
DRUG

linaclotide

oral

DRUG

placebo

oral

Trial Locations (4)

Unknown

Hokkaido

Kansai

Kantou

Kyusyu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01714843 - A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter